CHRISTINE PLUMMER: Open Payments
NPI 1326047242 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 15 payments from 10 companies in 2025. Trend: 2023 $1,575 · 2024 $1,711 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $62 |
| Amgen Inc. | 3 | $60 |
| Travere Therapeutics, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: TARPEYO, KRYSTEXXA, Kerendia, JYNARQUE, ACTHAR, Veltassa, ULTOMIRIS, TAVNEOS.
Industry payments across NC — which companies pay providers there.
